Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12559545 | Human hendra virus and nipah virus antibodies and methods of use therefor | 🖼🧊📄§ | 2026-02-24 | 2040-11-12 | 0 | 31 |
| 12558325 | Methods for improving neurological diseases and disorders | 🖼🧊📄§ | 2026-02-24 | 2043-02-09 | 0 | 31 |
| 12558411 | Antigen composition for preventing or treating viral infectious diseases | 🖼🧊📄§ | 2026-02-24 | 2041-01-15 | 0 | 31 |
| 12558375 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-02-24 | 2042-08-03 | 0 | 31 |
| 12558354 | Tumor necrosis factor alpha (TNF-alpha) small molecule inhibitor | 🖼🧊📄§ | 2026-02-24 | 2040-11-05 | 0 | 31 |
| 12558392 | Herbal oral compositions having the properties for supporting and enhancing musculoskeletal health and method of manufacturing the same | 🖼🧊📄§ | 2026-02-24 | 2045-07-23 | 0 | 31 |
| 12559553 | IL-31 modulators for treating FXR-induced pruritus | 🖼🧊📄§ | 2026-02-24 | 2042-06-17 | 0 | 31 |
| 12558339 | Composition comprising (7S)-(+)-cyclopentyl carbarmic acid, 8,8-dimethyl-2-oxo-6,7-dihydro-2H,8H-pyrano[3,2-g]chromen-7-yl-ester as active ingredient for prevention, alleviation, or treatment of eye disease | 🖼🧊📄§ | 2026-02-24 | 2042-01-05 | 0 | 31 |
| 12558437 | Compositions and methods for epigenetic regulation of HBV gene expression | 🖼🧊📄§ | 2026-02-24 | 2044-07-02 | 0 | 31 |
| 12559540 | ApoM-Fc fusion proteins and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2038-08-15 | 0 | 31 |
| 12559563 | Müllerian inhibiting substance type 2 receptor (MISIIR)-specific CAR T cells for the treatment of ovarian cancer and other gynecologic malignancies | 🖼🧊📄§ | 2026-02-24 | 2040-04-14 | 0 | 31 |
| 12558385 | Lactobacillus plantarum compositions and uses thereof | 🖼🧊📄§ | 2026-02-24 | 2039-06-13 | 0 | 31 |
| 12558376 | Tissue repair by activated cells | 🖼🧊📄§ | 2026-02-24 | 2039-08-29 | 0 | 31 |
| 12559532 | Embryonic angiogenesis markers and diagnostic and therapeutic strategies based thereon | 🖼🧊📄§ | 2026-02-24 | 2044-06-20 | 0 | 31 |
| 12558577 | Anti-human Trop-2 antibody and application thereof | 🖼🧊📄§ | 2026-02-24 | 2040-10-12 | 0 | 31 |
| 12559733 | Optimization of type IV BRAF inhibitors for the treatment of melanoma | 🖼🧊📄§ | 2026-02-24 | 2041-08-23 | 0 | 31 |
| 12559546 | Methods of identifying HIV patients sensitive to therapy with gp120 CD4 binding site-directed antibodies | 🖼🧊📄§ | 2026-02-24 | 2041-11-09 | 0 | 31 |
| 12558327 | Methods and compositions for treating sleep apnea | 🖼🧊📄§ | 2026-02-24 | 2040-02-07 | 0 | 31 |
| 12558421 | Anti-TIGIT antibodies, anti-PVRIG antibodies and combinations thereof | 🖼🧊📄§ | 2026-02-24 | 2043-05-23 | 0 | 31 |
| 12559451 | System for producing remote sensing data from near earth orbit | 🖼🧊📄§ | 2026-02-24 | 2045-03-13 | 0 | 31 |
| 12558424 | T cells having enhanced anti-tumor activity | 🖼🧊📄§ | 2026-02-24 | 2040-08-06 | 0 | 31 |
| 12559473 | Substituted indazoles, methods for the production thereof, pharmaceutical preparations that contain said new substituted indazoles, and use of said new substituted indazoles to produce drugs | 🖼🧊📄§ | 2026-02-24 | 2044-04-30 | 0 | 31 |
| 12559458 | Co-crystals or salts of psilocin and methods of treatment therewith | 🖼🧊📄§ | 2026-02-24 | 2043-03-03 | 0 | 31 |
| 12558398 | Inflammatory disease treatment with complement inhibitors | 🖼🧊📄§ | 2026-02-24 | 2040-06-04 | 0 | 31 |
| 12551543 | Vaccine compositions comprising C—C motif chemokine 22 (CCL22) or fragments thereof | 🖼🧊📄§ | 2026-02-17 | 2042-03-10 | 0 | 31 |
| 12552850 | GLP-1/GIP dual agonist, long-acting conjugate thereof, and pharmaceutical composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-10-18 | 0 | 31 |
| 12551734 | Betacoronavirus mRNA vaccines | 🖼🧊📄§ | 2026-02-17 | 2044-12-23 | 0 | 31 |
| 12551511 | Methods to differentiate stem cells into hormone-producing cells | 🖼🧊📄§ | 2026-02-17 | 2042-09-09 | 0 | 31 |
| 12551475 | Methods and compositions for treating RNA viral infections | 🖼🧊📄§ | 2026-02-17 | 2041-06-01 | 0 | 31 |
| 12552834 | Selective MENA binding peptides | 🖼🧊📄§ | 2026-02-17 | 2042-01-25 | 0 | 31 |
| 12551506 | Differentiation of olfactory mucosa derived mesenchymal stem cells to schwann cells for peripheral nerve repair | 🖼🧊📄§ | 2026-02-17 | 2042-04-25 | 0 | 31 |
| 12551479 | Acyl-protein thioesterase inhibitor for the treatment and/or prevention of Huntington's disease | 🖼🧊📄§ | 2026-02-17 | 2040-02-21 | 0 | 31 |
| 12552733 | Terpenophenolic compounds and their use | 🖼🧊📄§ | 2026-02-17 | 2041-03-31 | 0 | 31 |
| 12552788 | IMDQ-PEG-CHOL adjuvant and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2041-10-07 | 0 | 31 |
| 12551522 | Herbal compositions and methods for treating and preventing SARS-CoV-2 virus infection | 🖼🧊📄§ | 2026-02-17 | 2042-11-09 | 0 | 31 |
| 12551495 | Phytoecdysones and derivatives thereof for use in treating disordered respiratory function on viral infection | 🖼🧊📄§ | 2026-02-17 | 2041-03-24 | 0 | 31 |
| 12551523 | HIF-1 activator | 🖼🧊📄§ | 2026-02-17 | 2042-10-04 | 0 | 31 |
| 12551457 | Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics | 🖼🧊📄§ | 2026-02-17 | 2043-05-01 | 0 | 31 |
| 12551555 | Compositions and methods for potentiating immune activity | 🖼🧊📄§ | 2026-02-17 | 2042-06-10 | 0 | 31 |
| 12552796 | EED inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-02-17 | 2040-11-02 | 0 | 31 |
| 12551507 | Fat and medical uses thereof | 🖼🧊📄§ | 2026-02-17 | 2037-05-12 | 0 | 31 |
| 12552875 | Anti-human Cripto-1 antibody | 🖼🧊📄§ | 2026-02-17 | 2040-11-10 | 0 | 31 |
| 12551515 | Methods and compositions for treating cancer | 🖼🧊📄§ | 2026-02-17 | 2039-11-21 | 0 | 31 |
| 12551581 | Combination cancer immunotherapy with pentaaza macrocyclic ring complex | 🖼🧊📄§ | 2026-02-17 | 2041-12-30 | 0 | 31 |
| 12551521 | Compositions including pine bark extract, berryfruit extract and a source of l-theanine and uses thereof | 🖼🧊📄§ | 2026-02-17 | 2038-11-13 | 0 | 31 |
| 12551733 | Fusion antibody for presenting antigen-derived T cell antigen epitope or peptide containing same on cell surface, and composition comprising same | 🖼🧊📄§ | 2026-02-17 | 2041-02-05 | 0 | 31 |
| 12551562 | Methods and compositions for irreversible enzyme inhibition | 🖼🧊📄§ | 2026-02-17 | 2040-04-10 | 0 | 31 |
| 12552789 | 1H-pyrrolo[2,3-c]pyridine compounds and application thereof | 🖼🧊📄§ | 2026-02-17 | 2041-09-24 | 0 | 31 |
| 12551499 | Highly active compounds against COVID-19 | 🖼🧊📄§ | 2026-02-17 | 2043-09-15 | 0 | 31 |
| 12552782 | Analogs of nitrofuran antibiotics to combat resistance | 🖼🧊📄§ | 2026-02-17 | 2043-01-17 | 0 | 31 |